346
Views
111
CrossRef citations to date
0
Altmetric
Original Research

Sarcopenia correlates with systemic inflammation in COPD

, , , &
Pages 669-675 | Published online: 20 Feb 2017

References

  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • DonaldsonGCSeemungalTAPatelISAirway and systemic inflammation and decline in lung function in patients with COPDChest200512841995200416236847
  • HurstJRDonaldsonGCPereraWRUse of plasma biomarkers at exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006174886787416799074
  • RossRAtherosclerosis: an inflammatory diseaseN Engl J Med199934021151269887164
  • KotlerDPCachexiaAnn Intern Med2000133862263411033592
  • JohnsonPMVogtSKBurneyMWMugliaLJCOX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine productionAm J Physiol Endocrinol Metab20022823E650E65611832369
  • RaiszLGPhysiology and pathophysiology of bone remodelingClin Chem1999458 Pt 21353135810430818
  • GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
  • BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
  • VestboJPrescottEAlmdalTBody mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart StudyAm J Respir Crit Care Med20061731798316368793
  • ScholsAMSoetersPBDingemansAMMostertRFrantzenPJWoutersEFPrevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitationAm Rev Respir Dis19931475115111568484624
  • CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
  • Cruz-JentoftAJBaeyensJPBauerJMSarcopenia – European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older PeopleAge Ageing201039441242320392703
  • KalyaniRRCorriereMFerrucciLAge-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseasesLancet Diabetes Endocrinol201421081982924731660
  • No authors listedATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
  • No authors listedLung function testing: selection of reference values and interpretative strategiesAm Rev Respir Dis19911445120212181952453
  • JonesSEMaddocksMKonSSSarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitationThorax201570321321825561517
  • MarquisKDebigareRLacasseYMidthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002166680981312231489
  • WagnerPDPossible mechanisms underlying the development of cachexia in COPDEur Respir J200831349250118310396
  • LeeJYChonGRRheeCKCharacteristics of patients with chronic obstructive pulmonary disease at the first visit to a pulmonary medical center in Korea: the Korea COPD Subgroup Study team cohortJ Korean Med Sci201631455356027051239
  • SwallowEBReyesDHopkinsonNSQuadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary diseaseThorax200762211512017090575
  • BurtinCTer RietGPuhanMAHandgrip weakness and mortality risk in COPD: a multicentre analysisThorax2016711868726514408
  • de GodoyIDonahoeMCalhounWJMancinoJRogersRMElevated TNF-α production by peripheral blood monocytes of weight-losing COPD patientsAm J Respir Crit Care Med199615326336378564110
  • EidAAIonescuAANixonLSInflammatory response and body composition in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011648 Pt 11414141811704588
  • ScholsAMPulmonary cachexiaInt J Cardiol200285110111012163214
  • AgustíAGNogueraASauledaJSalaEPonsJBusquetsXSystemic effects of chronic obstructive pulmonary diseaseEur Respir J200321234736012608452
  • HoleDJWattGCDavey-SmithGHartCLGillisCRHawthorneVMImpaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population studyBMJ199631370597117168819439
  • SchünemannHJDornJGrantBJWinkelsteinWJrTrevisanMPulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health StudyChest2000118365666410988186
  • SteinerMCSarcopaenia in chronic obstructive pulmonary diseaseThorax200762210110317287301
  • ScholsAMBuurmanWAvan den BrekelAJDentenerMAWoutersEFEvidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary diseaseThorax19965188198248795671
  • CazzolaMNovelliGBiomarkers in COPDPulm Pharmacol Ther201023649350020471487